1. Home
  2. OLB vs XRTX Comparison

OLB vs XRTX Comparison

Compare OLB & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

HOLD

Current Price

$0.31

Market Cap

4.4M

Sector

Technology

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$2.04

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLB
XRTX
Founded
1993
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
4.3M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
OLB
XRTX
Price
$0.31
$2.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
260.8K
10.5K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
71.48
N/A
EPS
N/A
N/A
Revenue
$8,676,907.00
N/A
Revenue This Year
$12.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.35
52 Week High
$1.80
$3.60

Technical Indicators

Market Signals
Indicator
OLB
XRTX
Relative Strength Index (RSI) 45.31 45.47
Support Level $0.27 $2.00
Resistance Level $0.34 $2.24
Average True Range (ATR) 0.03 0.11
MACD 0.00 -0.01
Stochastic Oscillator 56.20 12.12

Price Performance

Historical Comparison
OLB
XRTX

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified FinTech company that focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. The company seeks to provide merchants with a wide range-of-products and services through the various online platforms, including financial and transaction processing services. It also has products that provide support for crowdfunding and other capital-raising initiatives. It supplements the online platforms with certain hardware solutions that are integrated with the online platforms. The company has two business segments: Fintech Services, which generates key revenue, and the Bitcoin Mining business segment.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

Share on Social Networks: